Adapting to the market's 'new normal'
IT HAS to be said that Manulife US Reit's debut on Friday which saw it trade below its US$0.83 offer price for the whole day before closing at US$0.79 was disappointing but not wholly unexpected.
Not because the offer was unattractive or was badly priced; in fact it was quite the opposite - by any measure, an instrument offering a yield of 7 per cent in today's zero interest rate environment is a rarity and should be viewed as attractive, especially one which comes with a strong brand name.
Logically, it should therefore have posted a stronger debut than it did; instead, it didn't and even though it didn't, very few observers expressed surprise at the counter's weak showing.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Capital Markets & Currencies
Europe: Stoxx 600 logs best day in three months as banks shine
US: Stocks rally after strong tech results
Mixed trading in Asia as investors watch for further macro data; STI down 0.2%
Vietnam delays launch of new stock trading system
Hong Kong bourse regains favour on hopes of a market revival
Asia: Markets rise as strong US tech earnings offset poor data